Changing a company's name is what pink sheet penny stocks do prior to a pump and dump scheme. My trading history goes back to trading CNKT and EGGS in the 1990s; I have never seen a set of proposals that so blatantly disregards shareholder value. Immolation of the company seems to be its fate: pennies on the dollar, fire sale of office furniture and lab equipment, Lanza moves on to another biotech, Wotten takes his millions and returns to the UK with his family. They did the ice bucket challenge -- how about the stock price challenge? We the common shareholders are about to get soaked. What propped up this stock since the R/S is unknown to me, but that support has now been removed, and "look out below" might be the key phrase today. We have gotten the chairs pulled out from under us. Elsiecat, I don't see how the line up of scientists or the new patent can hold in the face of more dilution and a murky future concerning release of phase 1 results and uplisting. It's a Murky Massachusetts Mystery! Could be a massacre! Red red red all day I predict -- double digit percentage drop. Ugh. and on 9/11.